Zavegepant
| CAS No. | 1337918-83-8 |
|---|---|
| MDL No. | N/A |
| MF | C36H46N8O3 |
| MW | 638.80 |
| InChI Key | JJVAPHYEOZSKJZ-JGCGQSQUSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Zavegepant is a urea derivative in which both amino groups are replaced by 4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidin-1-yl and {(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl}amino groups. It is a calcitonin gene-related peptide receptor antagonist, with its hydrochloride salt approved by the FDA for the acute treatment of migraine. It is classified as a quinolone, piperidinecarboxamide, urea, N-acylpiperazine, piperidine, and indazole. It is also the conjugate base of zavegepant(1+).
| CAS No. | 1337918-83-8 |
|---|---|
| Product Name | Zavegepant |
Biological Targets
CALCRL·RAMP1
Associated Conditions
migraine disorder·asthma·COVID-19
* The information provided here is compiled from public sources and is for reference only.
